Latest News

CSL and CEPI agreement on COVID-19 vaccine for Australia June 5, 2020

CSL has announced it will partner with the Coalition for Epidemic Preparedness Innovations to accelerate the development and manufacture of the COVID-19 vaccine under development at The University of Queensland.

US 'Operation Warp Speed' selects priority vaccines June 5, 2020

The US government's 'Operation Warp Speed' initiative is reported to have identified its priority COVID-19 vaccines that will receive additional funding and support.

Three years on pathways, then along comes this June 5, 2020

The industry spent almost three years working on a complex range of new processes for PBS decision-making - just as companies are coming to terms with these new processes along comes something entirely new.

Federal government commits $300m to global vaccine alliance June 5, 2020

Prime Minister Scott Morrison announced the contribution to the Global Vaccine Summit 2020 overnight.

BMS announces positive data for PBS-listed biologic June 5, 2020

Bristol Myers Squibb has announced positive results from a new study of its PBS-listed rheumatoid arthritis biologic ORENCIA (abatacept).

Pfizer Invites: ‘Life on the Other Side’ June 4, 2020

Industry, pharmacy, patient and academic leaders have been confirmed for the third 'Pfizer Invites' series that will take place as a webinar on 18 June.

Maybe investigate the issue rather than just get rid of it? June 4, 2020

Rather than simply ridding itself of unimplemented recommendations, maybe the government should be investigating the reasons why some companies are not accepting the outcome.

Medicines Australia has 'immediate concerns' over 'review and rescind' June 4, 2020

Medicines Australia said one of its immediate concerns is the very short time period after an initial recommendation for the PBAC to consider a rescission, particularly given the cost of a submission has more than doubled.

'Project Orbis' review for STA lung cancer therapy June 4, 2020

STA has announced its lung cancer therapy lurbinectedin has been granted provisional designation by the TGA and will be reviewed concurrently by other regulators under the ‘Project Orbis’ initiative.

COVID-19: Investors call for action to protect life sciences June 4, 2020

A COVID-19 response package to support the life science sector, which is valued at over $170 billion, is urgently needed says Dr Chris Nave, CEO of Australia’s largest life science investment fund.

Chris Bowen slams 'arbitrary deadline' that will 'only worsen' access June 3, 2020

Shadow health minister Chris Bowen says the proposal to review and rescind PBAC recommendations will only worsen access to medicines for Australian patients.

The 'rescind' and 'inactivate' fix to a political problem June 3, 2020

Can the PBAC even rescind its recommendations? Why has this emerged as an issue and how has it come about? Does it have something to do with Labor's focus on the issue and targeting of Mr Hunt over implemented recommendations?

Latest Video

Most Read

Pfizer Invites: ‘Life on the Other Side’

CSL and CEPI agreement on COVID-19 vaccine for Australia

Chris Bowen slams 'arbitrary deadline' that will 'only worsen' access

Three years on pathways, then along comes this

COVID-19: Investors call for action to protect life sciences

New Stories

CSL and CEPI agreement on COVID-19 vaccine for Australia

US 'Operation Warp Speed' selects priority vaccines

Three years on pathways, then along comes this

Federal government commits $300m to global vaccine alliance

BMS announces positive data for PBS-listed biologic

Pfizer Invites: ‘Life on the Other Side’

Maybe investigate the issue rather than just get rid of it?

Sign In

Latest Video

Most Read

Pfizer Invites: ‘Life on the Other Side’

CSL and CEPI agreement on COVID-19 vaccine for Australia

Chris Bowen slams 'arbitrary deadline' that will 'only worsen' access

Three years on pathways, then along comes this

COVID-19: Investors call for action to protect life sciences

Follow Us

New Stories

CSL and CEPI agreement on COVID-19 vaccine for Australia

US 'Operation Warp Speed' selects priority vaccines

Three years on pathways, then along comes this

Federal government commits $300m to global vaccine alliance

BMS announces positive data for PBS-listed biologic

Pfizer Invites: ‘Life on the Other Side’

Maybe investigate the issue rather than just get rid of it?